Concerto's clinical trial, ENS-002 for Atopic Dermatitis in Adults, is now recruiting.More information
TechnologyPartnerships
Contact
About Us

Reinventing humanity’s relationship with microbes.

Latest News & Press
Bio.News 7 11 2024
NIH Innovation Zone 2024: Concerto Biosciences illuminates collaboration of microbes
From Concerto 6 26 2024
Concerto Biosciences Receives FDA Investigational New Drug Clearance for Live Biotherapeutic Product to Treat Atopic Dermatitis
Dermatology Times 6 26 2024
FDA Grants Investigational New Drug Clearance for Ensemble No.2 for Phase 1 Atopic Dermatitis Trial
Microbe Musings 4 29 2024
Jared Kehe: Unlock the Microbial Sound of Music
Homeworld Collective 12 19 2023
Communion: The Future of Biotech, by CSO Jared Kehe
Saturday Startup Stories 11 26 2023
Upgrading Humanity's Microbes
See All News
Concerto team members in lab
Concerto team members in lab
Concerto team members m
Our Mission

We create safe, effective microbial products for our world.

First came antibiotics. Then came genetic engineering. Concerto is catalyzing a third wave of microbial technologies to capture what microbes do best: Protect the health of our bodies, our food, and our planet. Accessing these microbial ecology-inspired products requires rigorous discovery science, a strong collaborative culture, and an unyielding commitment to improvement.
Our Values

Grow by experimenting 

Work rigorously 

Listen intently 

Act with compassion 


Permission to Play

Concerto embraces a foundational set of additional values that we believe ought to be evident in any startup.

Harness microbial ecology with Concerto to develop new, transformative products. 

Partner With Us

Microbes, like humans, are stronger together than they ever could be alone.
Visit Us

750 Main Street

Cambridge, MA 02139

concerto-biosciences@concertobioinfo@concertobio.com
© 2024 Concerto Biosciences, Inc. All rights reserved.